Intelligence / Healthtech / New Clinical Trials / BlissBot, Inc
Clinicaltrial registered27 Oct 2026
BlissBot, Inc
27 Oct 2026: Trial registered · Evaluation of a Novel Quantum-Inspired Intervention (QII) for Children With Autism Spectrum Disorder: A Global Confirmatory Study. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 27 Oct 2026
- Title
- Evaluation of a Novel Quantum-Inspired Intervention (QII) for Children With Autism Spectrum Disorder: A Global Confirmatory Study
- Conditions
- Autism Spectrum Disorder, Autism Spectrum Disorder (ASD, ASD
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Reference
- NCT07898787
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at BlissBot, Inc
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.